Keybank National Association OH Sells 6,944 Shares of The Cooper Companies, Inc. $COO

Keybank National Association OH lowered its stake in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 34.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,012 shares of the medical device company’s stock after selling 6,944 shares during the quarter. Keybank National Association OH’s holdings in Cooper Companies were worth $892,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of COO. Sustainable Growth Advisers LP bought a new stake in shares of Cooper Companies in the second quarter worth about $240,881,000. Ameriprise Financial Inc. increased its holdings in Cooper Companies by 98.8% during the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after buying an additional 1,683,561 shares during the last quarter. Franklin Resources Inc. lifted its stake in Cooper Companies by 7,723.3% in the 2nd quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company’s stock valued at $111,686,000 after purchasing an additional 1,549,450 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Cooper Companies by 96.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock valued at $212,519,000 after acquiring an additional 1,525,693 shares during the period. Finally, Findlay Park Partners LLP boosted its holdings in shares of Cooper Companies by 312.5% during the 2nd quarter. Findlay Park Partners LLP now owns 1,815,900 shares of the medical device company’s stock worth $129,219,000 after buying an additional 1,375,657 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $80.92 on Thursday. The Cooper Companies, Inc. has a 1-year low of $61.78 and a 1-year high of $97.21. The stock has a fifty day simple moving average of $81.24 and a two-hundred day simple moving average of $74.40. The firm has a market cap of $15.86 billion, a price-to-earnings ratio of 43.04, a price-to-earnings-growth ratio of 2.27 and a beta of 1.03. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the company earned $1.04 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Insider Activity at Cooper Companies

In other news, Director Cynthia L. Lucchese bought 1,784 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The shares were acquired at an average price of $84.06 per share, with a total value of $149,963.04. Following the acquisition, the director owned 9,445 shares of the company’s stock, valued at approximately $793,946.70. The trade was a 23.29% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Holly R. Sheffield bought 1,230 shares of Cooper Companies stock in a transaction that occurred on Tuesday, December 16th. The shares were acquired at an average price of $80.75 per share, with a total value of $99,322.50. Following the completion of the transaction, the insider owned 39,052 shares of the company’s stock, valued at $3,153,449. This represents a 3.25% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 16,014 shares of company stock valued at $1,304,416 in the last quarter. 1.98% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently commented on COO. Barclays set a $98.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a research note on Monday, January 26th. Morgan Stanley increased their price target on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. Citigroup reaffirmed a “neutral” rating and set a $88.00 price target (up previously from $72.00) on shares of Cooper Companies in a research note on Monday, December 8th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Finally, Wells Fargo & Company raised their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.77.

Check Out Our Latest Report on Cooper Companies

Cooper Companies News Summary

Here are the key news stories impacting Cooper Companies this week:

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Featured Stories

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.